Skip to main content
Equibles
MOH logo

MOH · Molina Healthcare, Inc. · Metrics

Track MOH — free

Use MOH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MOH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$220.27 +0.55 (+0.25%)
S&P 400 member Russell 1000 member Rebalance outlook locked
Customer concentration — top customer 13% of revenue

One customer — 13% of revenue (the year ended December 31, 2025)

“Instances where these contracts were at least 10% of our total premium revenue for the year ended December 31, 2025 were California with 10%, Texas with 13%, and Washington with 10%.”

One customer — 10% of revenue (the year ended December 31, 2025)

“Instances where these contracts were at least 10% of our total premium revenue for the year ended December 31, 2025 were California with 10%, Texas with 13%, and Washington with 10%.”

One customer — 10% of revenue (the year ended December 31, 2025)

“Instances where these contracts were at least 10% of our total premium revenue for the year ended December 31, 2025 were California with 10%, Texas with 13%, and Washington with 10%.”
View the 10-K filed Feb 10, 2026
Market Cap
$11.47B
Shares
52.20M
Volume · Oct 21 12.89K Avg daily vol (3M) 887.58K

MOH metrics

80 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$219.72
Market cap
$11.47B

Price action

20 metrics
Price change (1W)
+4.9%
Price change (30D)
+11.1%
Price change (3M)
-3.0%
Price change (6M)
+45.5%
Price change (YTD)
+26.6%
Price change (1Y)
+11.3%
Trailing year
Price change (5Y)
-24.3%
52-week high
$242.88
52-week low
$122.65
Change from 52-week high
-9.5%
Change from 52-week low
+79.1%
Annualized volatility
53.4%
Annualized volatility (3M)
39.9%
Beta
-0.1
RSI (14D)
67.8
Price vs SMA 50
+9.8%
Price vs SMA 200
+19.4%
Avg volume (3M)
887,583
Relative volume
1.2
Average dollar volume
$181.93M

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
52.20M

Valuation

12 metrics
P / E (TTM)
1,220.7
Trailing earnings · reciprocal yield 0.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.2×
reciprocal yield 405.8%
P / book
2.6
reciprocal yield 38.0%
FCF yield
—
TTM · current market cap
Buyback yield
4.6%
P / FCF
—
P / operating cash flow
30.1
reciprocal yield 3.3%
Earnings yield
-0.1%

Historical valuation

8 metrics
P / E historical average (3Y)
17.5×
reciprocal yield 5.7%
P / E historical average (5Y)
19.7×
reciprocal yield 5.1%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
4.6%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-22
Last earnings
2026-07-23

Profitability

9 metrics
Gross margin
—
Operating margin
0.5%
Trailing 12 months
Net margin
0.0%
Gross profit (TTM)
$2.30B
Operating profit (TTM)
$203.00M
Net income (TTM)
−$7.00M
Trailing 12 months
Diluted EPS (TTM)
$0.18
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$866.85
Gross profit per diluted share (TTM)
$35.88
Operating profit per diluted share (TTM)
$3.87
EBITDA per diluted share (TTM)
$7.14
Net income per diluted share (TTM)
$-0.21
Operating cash flow per diluted share (TTM)
$7.22
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$79.78

Growth

11 metrics
Revenue growth YoY
-4.8%
Year over year
Net income growth YoY
-76.5%
Revenue (TTM)
$44.52B
Trailing 12 months
EPS growth YoY
-74.9%
Shares change YoY
-4.5%
Year over year · fewer shares
Revenue CAGR (3Y)
+12.4%
Revenue CAGR (5Y)
+18.5%
EPS CAGR (3Y)
-13.0%
EPS CAGR (5Y)
-4.5%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-0.2%
Return on assets
0.0%
Debt / equity
—
Current ratio
1.7
EBITDA (TTM)
$371.00M
Free cash flow (TTM)
—
Quick ratio
1.7
Interest coverage
1.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$4.99B
Total assets
$16.00B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$365.00M
Capital expenditures (TTM)
$94.00M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$76.00M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
606
13F filer change QoQ
+76
Institutional ownership
110.7%
Conviction holders (share of 13F filers)
2.7%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-1.4%
Holder tenure
16.1
Price vs estimated holder cost
+20.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
24.6%

Short interest

3 metrics
Short interest
5.5%
Latest settlement · 4.8 days to cover
Days to cover
4.8d
Short-squeeze score
75 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1179929 CUSIP 60855R100 13F (30d) 86 filings 79 filers Visit website Investor relations